IMS Company Profiles:GlaxoSmithKline

  • ID: 662953
  • November 2013
  • 125 Pages
  • IMS Health
1 of 3

IMS Company Profiles gives a clear picture of the companies' strengths in terms of therapy areas and relevant marketed products as well as the future strategic direction of companies including R&D pipelines, analysts forecasts and events predicted to impact the future.

Use IMS Company Profiles to:

- As a first step to any in-depth competitor analysis exercice
- Understand the influence of companies within therapy areas
- Evaluate the future drivers and potential constraints of companies
- Review independent analysts forecasts and commentaries
- Gain a comprehensive picture of a company's strategic direction

Note: Product cover images may vary from those shown
2 of 3

1. Corporate Structure

2. Strategy Statement
Detailed insights into the strategic direction of the company
- Introduction
- Background
- M&A Activity
- Regional Strategy
- Therapy Focus
- R&D
- Licensing
- Future Prospects

3. Financial Review
Based on the company financial reports and complemented by the comments and forecasts of independent financial analysts - Net sales
- Net Profit
- Earnings per share
- R&D costs
- Sales by business sector
- Sales by geographic region
- Latest results
- Analyst comment

4. Product Portfolio
An extensive and detailed review of the company's portfolio of marketed products, providing insights into licensing, lifecycle management, competition
- Pharmaceutical Product by Therapeutic Areas
- Others categories can include (depending on the company): Nutritionals, Generics, OTC Products, Hospital Supplies, Animal Health, Fine Chemicals, Miscellaneous etc…

5. R&D Profile
Information on the progress through the R&D pipeline including clinical data, analyst forecasts
- Tabular summary of Products in R&D
- Products in development by Therapeutic Areas

6. Employee Data
Short section providing employee statistics when available

7. Licensing/Co-Marketing Agreements
A series of tables providing essential information on the company's licensing and co-marketing agreements for all products of commercial significance
- Marketed Products
- R&D Products
- General Research Collaborations

Major Events

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This company profile will be emailed to you. The company profile is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer Inc.